IGF1 and Alzheimer disease: Several studies have shown decreased IGF-1 levels in blood are associated with cognitive decline or risk of AD [182,183,184,185,186,187,188,189], and some studies found increasing IGF-1 in the serum of AD patients [190,191,192].